Preparation of dosage forms comprising a solid dispersion of microcrystalline active substances comprises homogenously dissolving a thermoplastic polymer, having glass transition temperature (T g) of at least 40[deg]C, and an active substance, initiating mass crystallization of the active substance at or above the T g of the polymer and cooling the mass below the T g of the polymer.